Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival
- PMID: 1714241
- PMCID: PMC1886087
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival
Abstract
Protein levels corresponding to nm23 were determined in normal and neoplastic breast tissues by immunoperoxidase staining. Nm23 protein levels were highest in normal breast epithelium, and lower in intraductal carcinomas. Based on nm23 staining, 39 infiltrating ductal carcinomas were separated into two groups: tumors with homogeneously high nm23 protein content, and tumors with low staining in either a homogeneous or heterogeneous pattern. Patients with low nm23 staining tumors, determined by three pathologists independently, had reduced survival times (alpha = 0.034, alpha = 0.012, alpha = 0.052 by the log rank test). Nm23 expression approached significance as an independent predictor of survival in Cox's proportional hazards model. The data provide the first correlation of low nm23 protein expression and reduced breast carcinoma patient survival.
Similar articles
-
Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.Gynecol Oncol. 1996 Mar;60(3):363-72. doi: 10.1006/gyno.1996.0056. Gynecol Oncol. 1996. PMID: 8774640
-
nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.Cancer. 1998 Apr 25;84(2):109-14. Cancer. 1998. PMID: 9570214
-
Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.Anticancer Res. 1996 Nov-Dec;16(6C):3987-90. Anticancer Res. 1996. PMID: 9042324
-
Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.J Pathol. 1998 Apr;184(4):401-7. doi: 10.1002/(SICI)1096-9896(199804)184:4<401::AID-PATH1220>3.0.CO;2-U. J Pathol. 1998. PMID: 9664906
-
Nm23 and tumour metastasis: basic and translational advances.Biochem Soc Symp. 1998;63:261-71. Biochem Soc Symp. 1998. PMID: 9513729 Review.
Cited by
-
Nm23 and breast cancer metastasis.Breast Cancer Res Treat. 1993;25(2):175-87. doi: 10.1007/BF00662142. Breast Cancer Res Treat. 1993. PMID: 8347849 Review.
-
Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.Br J Cancer. 1993 Nov;68(5):874-8. doi: 10.1038/bjc.1993.448. Br J Cancer. 1993. PMID: 8217603 Free PMC article.
-
Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma.Br J Cancer. 2004 Jun 1;90(11):2186-93. doi: 10.1038/sj.bjc.6601808. Br J Cancer. 2004. PMID: 15150613 Free PMC article.
-
Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion.Clin Exp Metastasis. 1993 Mar;11(2):151-8. doi: 10.1007/BF00114973. Clin Exp Metastasis. 1993. PMID: 8383029
-
Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.Jpn J Cancer Res. 1992 Aug;83(8):859-65. doi: 10.1111/j.1349-7006.1992.tb01991.x. Jpn J Cancer Res. 1992. PMID: 1356959 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials